HK68295A - Process for the preparation of cephalosporin derivatives - Google Patents
Process for the preparation of cephalosporin derivativesInfo
- Publication number
- HK68295A HK68295A HK68295A HK68295A HK68295A HK 68295 A HK68295 A HK 68295A HK 68295 A HK68295 A HK 68295A HK 68295 A HK68295 A HK 68295A HK 68295 A HK68295 A HK 68295A
- Authority
- HK
- Hong Kong
- Prior art keywords
- cephtazidime
- pentahydrate
- addition
- formula
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
New process for manufacturing cephtazidime pentahydrate having formula (III), characterized in that the ester group of the compound of formula (Ia) or an acid addition salt thereof is decomposed by using exclusively aqueous hydrochloric acid, and that the cephtazidime thus obtained is crystallized in the form of pentahydrate, directly from the reaction mixture by addition of bases or in that it is first isolated by the addition of acetone and/or ethanol or another water-soluble anti-solvent of cephtazidime dihydrochloride, and in that it is converted into pentahydrate by a method known per se.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0265786A AT387390B (en) | 1986-10-07 | 1986-10-07 | METHOD FOR PRODUCING THE ANTIBIOTIC (6R, 7R) -7- (2- (2-AMINO-4-THIAZOLYL) -2- (2-CARBOXY |
Publications (1)
Publication Number | Publication Date |
---|---|
HK68295A true HK68295A (en) | 1995-05-12 |
Family
ID=3538212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK68295A HK68295A (en) | 1986-10-07 | 1995-05-04 | Process for the preparation of cephalosporin derivatives |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0267427B1 (en) |
JP (2) | JP2507505B2 (en) |
KR (1) | KR950010597B1 (en) |
AT (2) | AT387390B (en) |
DE (1) | DE3777537D1 (en) |
ES (1) | ES2033277T3 (en) |
GR (1) | GR3004109T3 (en) |
HK (1) | HK68295A (en) |
WO (1) | WO1988002752A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106317081B (en) * | 2016-08-22 | 2018-08-31 | 山东罗欣药业集团恒欣药业有限公司 | A kind of anti-infectives cefotaxime crystalline compounds and its pharmaceutical composition |
CN106432280A (en) * | 2016-09-23 | 2017-02-22 | 临沂草之美医药科技有限公司 | Medicine ceftazidime crystalline compound for treating surgical operation infection |
CN106397458A (en) * | 2016-09-23 | 2017-02-15 | 临沂草之美医药科技有限公司 | Ceftazidime crystal compound as drug for treating infection during surgical operation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4329453A (en) * | 1979-10-02 | 1982-05-11 | Glaxo Group Limited | Cephalosporin antibiotic |
US4537959A (en) * | 1984-03-26 | 1985-08-27 | Eli Lilly And Company | Crystalline cephalosporin antibiotic salt |
US4616080A (en) * | 1984-07-02 | 1986-10-07 | Eli Lilly And Company | Simplified process of forming crystalline ceftazidime pentahydrate |
CA1239389A (en) * | 1984-11-08 | 1988-07-19 | Melvin G. Pleiss, Jr. | Crystallization process |
-
1986
- 1986-10-07 AT AT0265786A patent/AT387390B/en not_active IP Right Cessation
-
1987
- 1987-10-06 JP JP62506626A patent/JP2507505B2/en not_active Expired - Lifetime
- 1987-10-06 AT AT87114592T patent/ATE73809T1/en not_active IP Right Cessation
- 1987-10-06 DE DE8787114592T patent/DE3777537D1/en not_active Expired - Lifetime
- 1987-10-06 KR KR1019880700628A patent/KR950010597B1/en not_active IP Right Cessation
- 1987-10-06 EP EP87114592A patent/EP0267427B1/en not_active Expired - Lifetime
- 1987-10-06 WO PCT/EP1987/000574 patent/WO1988002752A1/en unknown
- 1987-10-06 ES ES198787114592T patent/ES2033277T3/en not_active Expired - Lifetime
-
1992
- 1992-03-19 GR GR920400466T patent/GR3004109T3/el unknown
-
1995
- 1995-05-04 HK HK68295A patent/HK68295A/en not_active IP Right Cessation
- 1995-11-07 JP JP7288491A patent/JP2594780B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH08283272A (en) | 1996-10-29 |
KR880701723A (en) | 1988-11-04 |
EP0267427A1 (en) | 1988-05-18 |
JPH01500906A (en) | 1989-03-30 |
ATA265786A (en) | 1988-06-15 |
GR3004109T3 (en) | 1993-03-31 |
JP2507505B2 (en) | 1996-06-12 |
EP0267427B1 (en) | 1992-03-18 |
WO1988002752A1 (en) | 1988-04-21 |
JP2594780B2 (en) | 1997-03-26 |
KR950010597B1 (en) | 1995-09-20 |
DE3777537D1 (en) | 1992-04-23 |
ES2033277T3 (en) | 1993-03-16 |
ATE73809T1 (en) | 1992-04-15 |
AT387390B (en) | 1989-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1258859A (en) | Carbostyril derivative and process for preparing same | |
PH24199A (en) | Derivatives of quinoline carboxylic acid,pharmaceutical composition containing same and process of preparing same | |
ES8801920A1 (en) | Process for the preparation of 1,8-bridged 4-quinolone-3-carboxylic acids. | |
GB1489609A (en) | 1-substituted 1h-tetrazole-5-thiols and the preparation thereof | |
HUT45984A (en) | Process for production of quinoline-derivatives and of their medically acceptable acid-additioned salts | |
PT83104A (en) | Novel guanidinomethylbenzoic acid derivatives | |
HK1012366A1 (en) | Process for the preparation of cyano-methoxyiminomethyl derivatives | |
EP0314098A3 (en) | Imide derivatives, their production and use | |
HUT55397A (en) | Process for producing mevalonic acid derivatives comprising thienopyridine ring and pharmaceutical compositions containing such active ingredient | |
HK68295A (en) | Process for the preparation of cephalosporin derivatives | |
NO170154C (en) | PROCEDURE FOR THE PREPARATION OF QUINOLINCARBOXYLIC ACIDS | |
ES2044908T3 (en) | PROCEDURE FOR THE PRODUCTION OF QUINAZOLINE DERIVATIVES. | |
HUT46686A (en) | Process for producing quinoline-carboxylic acid derivatives | |
DE69321749D1 (en) | Process for the preparation of ceftriaxone | |
DE3569236D1 (en) | Process for the preparation of 6-(low)alkoxy-1-naphthoic acids, possibly halogenated at position 5, and the corresponding esters | |
ATE80875T1 (en) | PROCESS FOR THE PRODUCTION OF COARSE CRYSTALLINE NICOTINE ACID OF HIGH PURITY. | |
EP0374410A3 (en) | 2-Azabicyclo[2.2.1]hept-5-ene-2-acetic acid, derivatives thereof and related compounds, process for the preparation of said compounds and the use of said compounds for the manufacture of N-phosphonomethylglycine | |
HUT49622A (en) | Process for producing derivatives of phosphoric acid | |
ATE62235T1 (en) | PROCESS FOR THE PREPARATION OF 6-AMINO-3-HYDRAZINO-PYRIDAZINE DERIVATIVES. | |
HUT47262A (en) | Process for production of derivatives of 2,1-benzotiazepin-2,2-dioxid-5-carbonic acid | |
HUT48570A (en) | Process for production of derivatives of mercaptobensoic acid | |
DE3679783D1 (en) | METHOD FOR PRODUCING BETA LACTAM DERIVATIVES. | |
PL277923A1 (en) | Method of obtaining ester-type derivatives of phtalazineacetic acid | |
GR880100409A (en) | Method for the synthesis of 1-cyclopropyl-6-fluoro-1,4 dihydro-4-oxo-7-chloro-quinoline-3-carboxylic acid as basis for the preparation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazine-quinoline-3-carboxylic acids | |
GB1464299A (en) | Process for producing pyrrogallol and derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |